-
Safety
-
Resources for You
-
-
MedWatch: The FDA Safety Information and Adverse Event Reporting Program
![]() |
Your FDA gateway for finding clinically important safety information and reporting serious problems with human medical products. |
-
What's New
- Pointe Scientific Liquid Glucose Hexokinase Reagent - Recall
[UPDATED 11/06/2009] Recall classified as Class I. Nationwide recall of all size kits. The reagents have been found to fail linearity at >200mg/dL that results in inaccurate glucose values above this range. Posted 10/30/2009 - Stiff Nights - product contains undeclared drug ingredient
Consumers warned that product sold as a dietary supplement contains sulfoaildenafil. Posted 11/05/2009 - Centurion Medical Products - Premie Pack and Meconium Pack - Recall
Kits recalled because the pediatric tracheal tubes were manufactured with an internal diameter smaller than indicated on the label. Posted 11/04/2009 - Bodybuilding.com Brand Dietary Supplements - Sold on Internet
Dietary supplements recalled due to undeclared steroids in products with risk of acute liver injury. Posted 11/03/2009 - Unomedical Manual Pulmonary Resuscitator - Recall
[UPDATED 11/03/2009] Recall classified as Class I - FDA Patient Safety News Video Broadcasts
November 2009 video news show for healthcare professionals, covering safety alerts, recalls, product approvals, and important tips on protecting patients. Posted 11/03/2009 - Byetta (exenatide) - Renal Failure
Cases of altered kidney function, including acute renal failure and renal insufficiency, in patients using Byetta. Posted 11/02/2009 - Cordis CROSSOVER Sheath Introducer - Recall
Nationwide recall due to stretching or fracture of the sheath during use. Posted 10/30/2009 - Accusure Insulin Syringes (Qualitest Pharmaceuticals) - Recall
Nationwide recall of all lots of product due to potential for needle to become detached from syringe during use. Posted 10/27/2009 - Peramivir IV
Investigational antiviral drug approved for emergency use in H1N1 influenza infection; mandatory reporting of adverse events required by healthcare providers. Posted 10/24/2009, UPDATED 10/30/2009 - Rituxan (rituximab) - PML
Third case of PML reported, the first case of PML in a patient with rheumatoid arthritis treated with Rituxan who has not previously received treatment with a TNF antagonist. Posted 10/23/2009 - Ketorolac Tromethamine Injection, USP 30 mg/mL; 1mL and 2mL Single Dose Vials -- Recall
[UPDATED 11/3/2009]recall expanded to include all lots of product - September 2009
Monthly Safety Labeling Changes - Summary of revisions to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS, PPI/Medication Guide sections of drug Prescribing Information. Posted 10/19/2009 - Medical Device Power Cords Safety Investigation: Initial Communication
Reports of sparking, charring, and fires from device power cords. Posted 10/19/2009 - Tamiflu (oseltamivir) for Oral Suspension
[UPDATED 10/16/2009] Consumers warned of unapproved and illegal H1N1 drug products purchased over the internet. - Unapproved Drugs: Enforcement Actions
FDA directed four companies to stop making and distributing 30 mg and 60 mg codeine sulfate tablets that lack the required FDA approval. Posted 10/16/2009 - Dexferrum (iron dextran injection) - Labeling Change
Risk of anaphylactic-type reactions, including fatalities, have followed the parenteral administration of iron dextran injection. Posted 10/16/2009
-
-
Spotlight
-
-
Recalls & Alerts
-
-
Stay Informed
-
Contact Us
- 1-800-332-1088
- 1-800-FDA-0178 Fax
Report a Serious Problem
Regular Mail: Use postage-paid FDA Form 3500
Mail to: MedWatch 5600 Fishers Lane
Rockville, MD 20852-9787
-
-
-


